Biosimulation Technology

Global Market Trajectory & Analytics

MCP-7920

EXECUTIVE ENGAGEMENTS

POOL

461
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

92
Interactions with Platform & by Email

PARTICIPANTS

18
Unique # Participated

VALIDATIONS

7
Responses Validated*

COMPANIES

22
Responses Validated*
* Login for a full stack data experience

DATE

APR 2021

TABLES

102

PAGES

154

EDITION

15

PRICE

USD 5450

CODE

MCP-7920


COMPETITIVE METRICS

COMPANY

D S N T

% *

Accelsiors CRO

Advanced Chemistry Development, Inc. (ACD/Labs)

Aegis Technologies Group

Aptuit LLC

Bell Medical Solutions, Inc.

Centre for Human Drug Research (CHDR)

Certara Holding, Inc.

Chemical Computing Group

Cyprotex Limited

Dynakin, S.L.

*Login to Participate & View Data Stacks
View 22 Companies...

SUBMIT
Note: Best viewed in Landscape Mode
  

HIGHLIGHTS & REPORT INDEX

Global Biosimulation Technology Market to Reach $4.2 Billion by 2026

Amid the COVID-19 crisis, the global market for Biosimulation Technology estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$4.2 Billion by 2026, growing at a CAGR of 14.9% over the analysis period. Software, one of the segments analyzed in the report, is projected to record a 14.1% CAGR and reach US$3.3 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Services segment is readjusted to a revised 16.8% CAGR for the next 7-year period.

The U.S. Market is Estimated at $622.1 Million in 2021, While China is Forecast to Reach $730.2 Million by 2026

The Biosimulation Technology market in the U.S. is estimated at US$622.1 Million in the year 2021. China, the world`s second largest economy, is forecast to reach a projected market size of US$730.2 Million by the year 2026 trailing a CAGR of 14.3% over the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 13.1% and 12.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 11% CAGR.

SELECT PLAYERS

3DS BIOVIA; Advanced Chemistry Development, Inc. (ACD/Labs); Certara USA, Inc.; Genedata AG; Schrodinger LLC

SEGMENTS

» Product (Software, and Services) » Application (Drug Development, Drug Discovery, and Other Applications) » End-Use (Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities, and Academic Research Institutions)

GEOGRAPHIES

» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

TABLE OF CONTENTS

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
World Current & Future Analysis for Biosimulation Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Biosimulation Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
World Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Drug Development by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Drug Development by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Pharmaceutical & Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Pharmaceutical & Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for CROs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for CROs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Regulatory Authorities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Regulatory Authorities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
World Current & Future Analysis for Academic Research Institutions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
World 7-Year Perspective for Academic Research Institutions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
UNITED STATES
USA Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
USA Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2020 & 2027
USA Current & Future Analysis for Biosimulation Technology by End-Use - Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
USA 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions for the Years 2020 & 2027
CANADA
Canada Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Canada Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2020 & 2027
Canada Current & Future Analysis for Biosimulation Technology by End-Use - Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Canada 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions for the Years 2020 & 2027
JAPAN
Japan Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Japan Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2020 & 2027
Japan Current & Future Analysis for Biosimulation Technology by End-Use - Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Japan 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions for the Years 2020 & 2027
CHINA
China Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
China Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2020 & 2027
China Current & Future Analysis for Biosimulation Technology by End-Use - Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
China 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions for the Years 2020 & 2027
EUROPE
Europe Current & Future Analysis for Biosimulation Technology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Biosimulation Technology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
Europe Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Europe Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2020 & 2027
Europe Current & Future Analysis for Biosimulation Technology by End-Use - Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Europe 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions for the Years 2020 & 2027
FRANCE
France Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
France Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2020 & 2027
France Current & Future Analysis for Biosimulation Technology by End-Use - Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
France 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions for the Years 2020 & 2027
GERMANY
Germany Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Germany Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2020 & 2027
Germany Current & Future Analysis for Biosimulation Technology by End-Use - Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Germany 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions for the Years 2020 & 2027
ITALY
Italy Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Italy Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2020 & 2027
Italy Current & Future Analysis for Biosimulation Technology by End-Use - Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Italy 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions for the Years 2020 & 2027
UNITED KINGDOM
UK Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
UK Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2020 & 2027
UK Current & Future Analysis for Biosimulation Technology by End-Use - Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
UK 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions for the Years 2020 & 2027
REST OF EUROPE
Rest of Europe Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2020 & 2027
Rest of Europe Current & Future Analysis for Biosimulation Technology by End-Use - Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of Europe 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions for the Years 2020 & 2027
ASIA-PACIFIC
Asia-Pacific Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2020 & 2027
Asia-Pacific Current & Future Analysis for Biosimulation Technology by End-Use - Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Asia-Pacific 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions for the Years 2020 & 2027
REST OF WORLD
Rest of World Current & Future Analysis for Biosimulation Technology by Product - Software and Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Biosimulation Technology by Product - Percentage Breakdown of Value Sales for Software and Services for the Years 2020 & 2027
Rest of World Current & Future Analysis for Biosimulation Technology by Application - Drug Development, Drug Discovery and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Biosimulation Technology by Application - Percentage Breakdown of Value Sales for Drug Development, Drug Discovery and Other Applications for the Years 2020 & 2027
Rest of World Current & Future Analysis for Biosimulation Technology by End-Use - Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
Rest of World 7-Year Perspective for Biosimulation Technology by End-Use - Percentage Breakdown of Value Sales for Pharmaceutical & Biotechnology Companies, CROs, Regulatory Authorities and Academic Research Institutions for the Years 2020 & 2027
Total Companies Profiled: 22

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com